| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Revenue | $784.8M | +34.3% |
| Cost of Revenue | $327.8M | +20.4% |
| Gross Profit | $457.0M | +46.4% |
| R&D Expense | $353.2M | +6.3% |
| SG&A Expense | $174.3M | +19.8% |
| Operating Income | -$70.5M | +57.4% |
| Pre-tax Income | -$57.9M | +62.6% |
| Income Tax | $7.0M | -80.7% |
| Net Income | -$64.9M |
| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $364.2M | +29.3% |
| Short-term Investments | $79.4M | -21.0% |
| Accounts Receivable | $64.5M | +18.4% |
| Inventory | $95.6M | -9.5% |
| Current Assets | $674.0M | +12.0% |
| Total Assets | $1.27B | +3.8% |
| Current Liabilities | $143.8M | +46.9% |
| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $95.7M | +788.1% |
| Capital Expenditures | $29.9M | +154.7% |
| Investing Cash Flow | -$12.0M | -110.6% |
| Financing Cash Flow | -$1.1M | +97.6% |
| Free Cash Flow | $65.8M | +356.4% |
| +66.0% |
| EPS (Basic) | -$1.98 | +66.6% |
| EPS (Diluted) | -$1.98 | +66.6% |
| Total Liabilities |
| $174.9M |
| +22.6% |
| Stockholders' Equity | $1.09B | +1.3% |